Privacy Notice, and An easy decision Has Buffett Become an Expert on Big Pharma? Is Platinum Group Metals Limited (PLG) A Good Stock To Buy? Bristol Myers Squibb (BMY Quick Quote BMY - Free Report) closed the most recent trading day at $60.77, moving -0.77% from the previous trading … An easy decision EPS $6.25-$6.35; FactSet consensus $6.28, Bristol Myers sees 2020 revenue $41.5 bln-$42.0 bln; FactSet consensus $42.0 bln, Bristol Myers Q3 Eliquis revenue up 9% to $2.10 bln; FactSet consensus $2.13 bln, Bristol Myers Squibb Co. stock rises Tuesday, outperforms market, Bristol Myers Squibb Co. stock rises Monday, still underperforms market, Schrödinger in drug development agreement with Bristol Myers worth up to $2.7 billion in milestone and royalty payments, Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors, Bristol Myers Squibb Co. stock rises Thursday, still underperforms market, Bristol Myers Squibb Co. stock falls Wednesday, underperforms market, Bristol Myers Squibb Co. stock falls Tuesday, still outperforms market. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always […], Analyst Report: Bristol-Myers Squibb Company. BMY: Get the latest Bristol-Myers Squibb stock price and detailed information including BMY news, historical charts and realtime prices. 63.05 0.00 (0.00%)After hours: 3:26PM EST, Subscribe to Premium to view Fair Value for BMY. There are currently no items in this Watchlist. Its shares trade at only a little over eight times expected earnings -- well below most of its peers. Forward-looking statements contained on this website should be evaluated together with the many uncertainties that affect Bristol Myers Squibb's business, particularly those identified in the cautionary factors discussion in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. The company was founded in August 1933 and is headquartered in New York, NY. Bristol-Myers Squibb (BMY) Catches Eye: Stock Jumps 6.8% Bristol-Myers Squibb Company BMY was a big mover last session, as the company saw its shares rise nearly 7% on the day. Bristol Myers Squibb offers a current dividend yield of 3% against the S&P 500 s average of about 2%. BMY | Complete Bristol Myers Squibb Co. stock news by MarketWatch. Visit a quote page and your recently viewed tickers will be displayed here. Discover new investment ideas by accessing unbiased, in-depth investment research, NYSE - NYSE Delayed Price. Bristol-Myers Squibb Germany Sie können sich an unseren EU-Datenschutzbeauftragten unter [email protected] wenden, um Ihre Datenschutzrechte auszuüben und um Ihre Bedenken oder Fragen in Bezug auf den Umgang mit Ihren personenbezogenen Daten durch die Bristol-Myers Squibb GmbH & Co. KGaA zu äußern. View the latest Bristol Myers Squibb Co. (BMY) stock price, news, historical charts, analyst ratings and financial information from WSJ. View real-time stock prices and stock quotes for a full financial overview. Bristol-Myers Squibb's (NYSE:BMY) Stock Price Has Reduced 11% In The Past Five Years By Simply Wall St Published November 01, 2020. Its shares trade at only a little over eight times expected earnings -- well below most of its peers. All rights reserved. Bristol Myers (BMY) obtains EC approval for Opdivo as a second-line treatment for unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma. In addition, any information contained on this website was current as of the date presented and should not be relied upon as representing our estimates as of any subsequent date. Historical and current end-of-day data provided by FACTSET. In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. Get today's Bristol Myers Squibb Co Rights stock price and latest BMY_r news as well as Bristol Myers Rights real-time stock quotes, technical analysis, full financials and more. While Bristol Myers Squibb stock has rallied by about 40% since its March lows, it still appears reasonably valued, trading at just about 10x projected … Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Have Watchlists? Is Mid Penn Bancorp (MPB) A Good Stock To Buy? This browser is no longer supported at MarketWatch. Copyright © 2020 MarketWatch, Inc. All rights reserved. Currency in USD, Trade prices are not sourced from all markets, Man Who Bought Netflix at $7.78 Says Buy This Now. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. Intraday Data provided by FACTSET and subject to terms of use. © 2020 Verizon Media. Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. Subscriber Agreement & Terms of Use, Create a list of the investments you want to track. We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. Bristol Myers Squibb Co. stock rises Monday, outperforms market, Bristol Myers Squibb Co. stock outperforms market on strong trading day, Bristol Myers Squibb Co. stock falls Thursday, underperforms market, No Stimulus? Bristol-Myers Squibb (BMY) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's giving away his top pick for free right here. Bristol-Myers Squibb Contingent Value Rights: Inspection Could Be Taking Place Or Imminent. All quotes are in local exchange time. These documents are available from the Securities and Exchange Commission, the Bristol Myers Squibb website or from Bristol Myers Squibb Investor Relations. By using this site you agree to the In aggregate, Bristol Myers Squibb currently has a Value Score of B, putting it into the top 40% of all stocks we cover from this look. This Expansion Still Looks Self-Sustaining, Says One Economist, Bristol Myers Stock Is Rising Because the Celgene Drugs It Acquired Boosted Earnings, Bristol Myers Squibb's stock gains with Eliquis sales jumping 9% during the third quarter, Revance's (RVNC) DaxibotulinumtoxinA BLA Decision Delayed, Biotech Stock Roundup: REGN's Cocktail Gets EUA, GILD & AMGN Provide Updates & More, Bristol Myers' (BMY) Opdivo Wins EC Nod for Esophageal Cancer, Tracking David Abrams' Abrams Capital Management Portfolio - Q3 2020 Update, Bristol Myers wins EU approval of Opdivo for esophageal cancer, Final Market Comments (Goodbye To Seeking Alpha), Schrödinger stock scales, upgraded by BofA after collaboration with BMY, Schrödinger inks multi-target drug discovery deal with Bristol-Myers Squibb, Bristol Myers Squibb: A Classic Buffett Style 'Fat Pitch', Bristol-Myers Squibb: CEO Giovanni Caforio At The Wolfe Research Healthcare Conference, Jim Simons' Firm's Top 5 Sells of the 3rd Quarter, Top Research Reports for Bank of America, Broadcom & Lowe's, Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio Presents at Wolfe Research Healthcare Conference (Transcript), Bristol-Myers Squibb Continues On Its Path To Becoming The Next Quarter Trillion-Dollar Company, Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS, Veeva Systems (VEEV) Boosts Portfolio of Cloud-Based Offerings, OncoSec: Undervalued And Continuing To Make Progress, Bristol Myers' (BMY) CAR T-Cell Therapy BLA Review Delayed.